Atrial fibrillation refers to quivering or irregular heartbeat (also termed as arrhythmia) that can lead to blood clots, stroke, heart failure, and other heart-related complications. The symptoms of atrial fibrillation include confusion, dizziness, fatigue, and fainting.
Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-toc-and-sample/2127
Rise in prevalence of atrial fibrillation in geriatric population, technological advancements, and increase in preference of catheter ablation for cardiac arrhythmia treatment drive the market. However, unfavorable preference to pharmaceutical interventions (drugs) over atrial fibrillation treatment devices restrain this growth. The growth opportunities in emerging economies of Asia-Pacific and LAMEA are expected to provide numerous opportunities for market growth during the forecast period.
The report segments the market based on procedure and geography. Based on procedure, the market is divided into catheter ablation and surgical ablation. Geographically, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, Italy, UK, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
Make an Enquiry before Buying @ https://www.alliedmarketresearch.com/purchase-enquiry/2127
The major companies profiled in the report include Biosense Webster, Inc., Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, AtriCure Inc., Biotronik SE & Co. KG, Cardiofocus, Inc., Ncontact, Inc., and Carima, Inc.
Key Benefits for Stakeholders
- The study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent investment pockets.
- It offers a quantitative analysis from 2016 to 2023, which is expected to enable the stakeholders to capitalize on prevailing market opportunities.
- Extensive analysis by product helps understand the various types of devices used for treatment of atrial fibrillation.
- Comprehensive analysis of all geographical regions is provided, which helps determine the prevailing opportunities.
- Key players are profiled and their strategies are analyzed thoroughly, which elucidates the competitive outlook of the global market.
Access Full Summary @ https://www.alliedmarketresearch.com/atrial-fibrillation-surgery-market
Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small- & medium-scale enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.
Allied Market Research provides one-stop solution right from data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients understand the significance and impact of market dynamics. The company applies client’s insight on the factors such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligence support to help clients transform into a prominent business firm.
5933 NE Win Sivers Drive
#205, Portland, OR 97220
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-114
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
This post was originally published on Trading Herald